Skip to main content
Premium Trial:

Request an Annual Quote

Pressure Bio, Omni Partner on Sample Prep Products

NEW YORK (GenomeWeb News) – Pressure BioSciences and Omni International today announced that they have entered into a marketing, distribution, and technology co-development pact for their respective sample preparation technologies.
 
Under the deal, the firms agreed to share market data, customer leads, technology assessments, and competitive information. They also will co-promote certain products at industry trade shows beginning next year and co-develop new instruments and consumables that combine Omni’s homogenization capabilities with Pressure Bio’s extraction capabilities.
 
Pressure Bio also granted Marietta, Ga.-based Omni a license to sell its PCT Shredder, a device that extracts nucleic acids, proteins, lipids, and small molecules from samples, to laboratories worldwide.
 
“We believe that combining the advantages of both technologies could offer the customer a range of solutions to ensure efficient extraction for many sample types, particularly those that continue to pose challenges in sample preparation,” Karl Jahn, president of Omni, said in a statement.
 
Jahn also disclosed that his firm will participate in a planned financing for South Easton, Mass.-based Pressure Bio, which recently said that it is actively seeking to raise additional capital.
 
Pressure Bio recently announced a restructuring that will include the reduction of eight positions at the firm and the closure of its R&D facility in Rockville, Md.
 

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.